公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma | Lee J; Zhang L.L; Wu W; Guo H; Li Y; Sukhanova M; Venkataraman G; Zhang H; Alikhan M; Lu P; Guo A; Galanina N; Andrade J; Wang M.L; Wang Y.L.; LI-HSING LEE | Blood Advances | 48 | 45 | |
2018 | Erratum: Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma (Blood Advances (2018) 2:16 (2039-2051) DOI: 10.1182/bloodadvances.201801604) | Lee J; Zhang L.L; Wu W; Guo H; Li Y; Sukhanova M; Venkataraman G; Huang S; Zhang H; Alikhan M; Lu P; Guo A; Galanina N; Andrade J; Wang M.L; Wang Y.L.; LI-HSING LEE | Blood Advances | 0 | 0 | |
2021 | Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2 | Wu W; Wang W; Franzen C.A; Guo H; Lee J; Li Y; Sukhanova M; Sheng D; Venkataraman G; Ming M; Lu P; Gao A; Xia C; Li J; Zhang L.L; Jiang V.C; Wang M.L; Andrade J; Zhou X; Lynn Wang Y; yuelynn.wang@fccc.edu.; LI-HSING LEE | Blood Advances | 9 | 8 |